HALO compared with CHE: revenue, margins and what each company keeps, and the suppliers and customers both name

HALOHalozyme Therapeutics, Inc.

Mkt capRevenueRevenue

CHEChemed Corp

Mkt capRevenueRevenue

Compare

HALOHalozyme Therapeutics, Inc.

CHEChemed Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only HALO 32

LLYEli Lilly and Company ("Lilly")customer

ABOSAcumen Pharmaceuticals, Inc. ("Acumen")customer

ARGXargenx BVBA ("argenx")customer

SKYESkye Bioscience, Inc. ("Skye Bioscience")customer

28 more · HALO chain ›

Shared 0

No shared counterparties.

Only CHE 8

—Covenant Health and Community Services, Inc d/b/a/ Covenant Care ("Covenant")unlistedsupplier

—Medicaid programunlistedcustomer

—Medicare and Medicaid programsunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—Medicare programunlistedcustomer

4 more · CHE chain ›

HALOHalozyme Therapeutics, Inc.

130.89▼−0.22%· post 130.16

Mkt cap$14.9BRevenue$481MQ2 FY26Revenue$1.4BFY25

CHEChemed Corp

534.36▼−1.40%· post 534.73

ClosedOct 30 '26

Mkt cap$7.0BRevenue$691MQ3 FY26Revenue$2.5BFY25

Compare

ClosedOct 30 '26

HALOHalozyme Therapeutics, Inc.

CHEChemed Corp

130.89▼−0.22%post 130.16

Price

534.36▼−1.40%post 534.73

$14.9B

Mkt cap

$7.0B

Q2 FY26$481M

Revenue

$691MQ3 FY26

FY25$1.4B

Revenue

$2.5BFY25

HALO130.89▼−0.22%vsCHE534.36▼−1.40%ClosedOct 30 '26